S&P 500   4,205.52
DOW   33,042.78
QQQ   349.98
The "How" and "Why" of Investing in 5G Stocks
⚡ 2,467% Return on Israeli Laser Company? (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Palantir: The "Sleeper" Play on the AI Revolution
66,000% upside on tiny biotech? (Ad)
Keep An Eye On These 5 Small-Cap AI Companies
AI Chip Stock Showdown: The Biggest Winners and Losers
Bear market expert makes new prediction (Ad)
Workday: Another AI Winner Melting-Up 
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.52
DOW   33,042.78
QQQ   349.98
The "How" and "Why" of Investing in 5G Stocks
⚡ 2,467% Return on Israeli Laser Company? (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Palantir: The "Sleeper" Play on the AI Revolution
66,000% upside on tiny biotech? (Ad)
Keep An Eye On These 5 Small-Cap AI Companies
AI Chip Stock Showdown: The Biggest Winners and Losers
Bear market expert makes new prediction (Ad)
Workday: Another AI Winner Melting-Up 
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.52
DOW   33,042.78
QQQ   349.98
The "How" and "Why" of Investing in 5G Stocks
⚡ 2,467% Return on Israeli Laser Company? (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Palantir: The "Sleeper" Play on the AI Revolution
66,000% upside on tiny biotech? (Ad)
Keep An Eye On These 5 Small-Cap AI Companies
AI Chip Stock Showdown: The Biggest Winners and Losers
Bear market expert makes new prediction (Ad)
Workday: Another AI Winner Melting-Up 
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.52
DOW   33,042.78
QQQ   349.98
The "How" and "Why" of Investing in 5G Stocks
⚡ 2,467% Return on Israeli Laser Company? (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Palantir: The "Sleeper" Play on the AI Revolution
66,000% upside on tiny biotech? (Ad)
Keep An Eye On These 5 Small-Cap AI Companies
AI Chip Stock Showdown: The Biggest Winners and Losers
Bear market expert makes new prediction (Ad)
Workday: Another AI Winner Melting-Up 
Taiwan Semiconductor Well Positioned for the AI Rush
NASDAQ:CROX

Crocs (CROX) Stock Forecast, Price & News

$114.33
+7.59 (+7.11%)
(As of 05/30/2023 ET)
Compare
Today's Range
$108.00
$114.63
50-Day Range
$104.09
$151.13
52-Week Range
$46.08
$151.32
Volume
2.16 million shs
Average Volume
1.64 million shs
Market Capitalization
$7.09 billion
P/E Ratio
11.56
Dividend Yield
N/A
Price Target
$158.00

Crocs MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.56 Rating Score
Upside/​Downside
38.2% Upside
$158.00 Price Target
Short Interest
Bearish
8.70% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.51mentions of Crocs in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$2.78 M Sold Last Quarter
Proj. Earnings Growth
10.49%
From $11.53 to $12.74 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.67 out of 5 stars

Consumer Discretionary Sector

34th out of 278 stocks

Rubber & Plastics Footwear Industry

2nd out of 4 stocks


CROX stock logo

About Crocs (NASDAQ:CROX) Stock

Crocs, Inc. engages in the design, development, manufacturing, worldwide marketing, sale, and distribution of casual footwear and accessories for men, women, and children. It operates through the following segments: North America, Asia Pacific, Europe, Middle East, Africa, and Latin America (EMEALA), and HEYDUDE Brand. The company was founded by Scott Seamans, George B. Boedecker, Jr., and Lyndon V. Hanson III in 2002 and is headquartered in Broomfield, CO.

Receive CROX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crocs and its competitors with MarketBeat's FREE daily newsletter.

CROX Stock News Headlines

Are Small Caps a Harbinger of Market Declines? (CROX)
The iShares Russell 2000 ETF outperformed the S&P 500 last week, but that may be short-lived. Small-cap momentum is often a bellwether for broad-market action.
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
This Is What Whales Are Betting On Crocs
Does Crocs (CROX) have a Long Runway for Growth?
Is It Too Late to Buy Crocs Stock?
Crocs Has Significant Room For Growth
Crocs: A Story For Bulls
See More Headlines
Receive CROX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Crocs and its competitors with MarketBeat's FREE daily newsletter.

CROX Company Calendar

Last Earnings
4/27/2023
Today
5/30/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Rubber & plastics footwear
Sub-Industry
Footwear
Current Symbol
NASDAQ:CROX
CUSIP
22704610
Employees
6,680
Year Founded
2002

Price Target and Rating

Average Stock Price Forecast
$158.00
High Stock Price Forecast
$185.00
Low Stock Price Forecast
$124.00
Forecasted Upside/Downside
+38.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
9 Analysts

Profitability

Net Income
$540.16 million
Pretax Margin
21.47%

Debt

Sales & Book Value

Annual Sales
$3.55 billion
Cash Flow
$12.43 per share
Book Value
$13.25 per share

Miscellaneous

Free Float
60,344,000
Market Cap
$7.09 billion
Optionable
Optionable
Beta
1.94

Social Links


Key Executives

  • Andrew ReesAndrew Rees
    Chief Executive Officer & Director
  • Michelle PooleMichelle Poole
    President
  • Anne MehlmanAnne Mehlman
    Chief Financial Officer & Executive Vice President
  • Michael Feliton
    Chief Information Officer & Senior Vice President
  • Daniel P. HartDaniel P. Hart
    Executive VP, Chief Legal & Risk Officer













CROX Stock - Frequently Asked Questions

Should I buy or sell Crocs stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Crocs in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CROX shares.
View CROX analyst ratings
or view top-rated stocks.

What is Crocs' stock price forecast for 2023?

9 equities research analysts have issued 12 month target prices for Crocs' shares. Their CROX share price forecasts range from $124.00 to $185.00. On average, they anticipate the company's stock price to reach $158.00 in the next year. This suggests a possible upside of 38.2% from the stock's current price.
View analysts price targets for CROX
or view top-rated stocks among Wall Street analysts.

How have CROX shares performed in 2023?

Crocs' stock was trading at $108.43 on January 1st, 2023. Since then, CROX stock has increased by 5.4% and is now trading at $114.33.
View the best growth stocks for 2023 here
.

Are investors shorting Crocs?

Crocs saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 5,200,000 shares, an increase of 7.7% from the April 30th total of 4,830,000 shares. Based on an average trading volume of 1,630,000 shares, the days-to-cover ratio is presently 3.2 days. Approximately 8.7% of the company's stock are sold short.
View Crocs' Short Interest
.

When is Crocs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CROX earnings forecast
.

How were Crocs' earnings last quarter?

Crocs, Inc. (NASDAQ:CROX) released its earnings results on Thursday, April, 27th. The textile maker reported $2.61 earnings per share for the quarter, topping analysts' consensus estimates of $2.15 by $0.46. The textile maker earned $884.20 million during the quarter, compared to analyst estimates of $857.76 million. Crocs had a net margin of 16.33% and a trailing twelve-month return on equity of 98.41%. The business's revenue for the quarter was up 33.9% compared to the same quarter last year. During the same quarter last year, the firm earned $2.05 EPS.

What guidance has Crocs issued on next quarter's earnings?

Crocs updated its second quarter 2023 earnings guidance on Thursday, April, 27th. The company provided EPS guidance of $2.83-$2.98 for the period, compared to the consensus earnings per share estimate of $3.23. The company issued revenue guidance of $1.03 billion-$1.05 billion, compared to the consensus revenue estimate of $1.06 billion.

What is Andrew Rees' approval rating as Crocs' CEO?

67 employees have rated Crocs Chief Executive Officer Andrew Rees on Glassdoor.com. Andrew Rees has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Crocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Crocs investors own include Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Bank of America (BAC), Denbury Resources (DNR), Cisco Systems (CSCO), Micron Technology (MU), AT&T (T) and Tesla (TSLA).

What is Crocs' stock symbol?

Crocs trades on the NASDAQ under the ticker symbol "CROX."

Who are Crocs' major shareholders?

Crocs' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.39%), FMR LLC (11.31%), State Street Corp (3.24%), Wellington Management Group LLP (2.63%), Geode Capital Management LLC (1.92%) and Two Sigma Investments LP (1.81%). Insiders that own company stock include Andrew Rees, Anne Mehlman, Beth J Kaplan, Daniel P Hart, Doreen A Wright, Douglas J Treff, Elaine L Boltz, Ian Bickley, Michelle Poole, Ronald Frasch, Shannon Sisler and Thomas J Smach.
View institutional ownership trends
.

How do I buy shares of Crocs?

Shares of CROX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Crocs' stock price today?

One share of CROX stock can currently be purchased for approximately $114.33.

How much money does Crocs make?

Crocs (NASDAQ:CROX) has a market capitalization of $7.09 billion and generates $3.55 billion in revenue each year. The textile maker earns $540.16 million in net income (profit) each year or $9.89 on an earnings per share basis.

How many employees does Crocs have?

The company employs 6,680 workers across the globe.

How can I contact Crocs?

Crocs' mailing address is 13601 Via Varra, Broomfield CO, 80020. The official website for the company is www.crocs.com. The textile maker can be reached via phone at (303) 848-7000, via email at brendon.frey@icrinc.com, or via fax at 303-468-4266.

This page (NASDAQ:CROX) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -